Microbial Biofilms: Identification, Resistance and Novel Drugs
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiofilm Strategies".
Deadline for manuscript submissions: 15 December 2024 | Viewed by 71
Special Issue Editors
2. UCIBIO-Applied Molecular Biosciences Unit, Forensics and Biomedical Sciences Research Laboratory, University Institute of Health Sciences (1H-TOXRUN, IUCS-CESPU), 4585-116 Gandra, Portugal
3. EPABE—Laboratory for Process Engineering, Environment, Biotechnology and Energy, ALiCE—Associate Laboratory in Chemical Engineering, Faculty of Engineering, University of Porto, 4200-465 Porto, Portugal
Interests: biofilms; Candida infections; AMR; polymicrobial infections; alternative treatments; natural compounds; oral infections
Special Issues, Collections and Topics in MDPI journals
Interests: biofilms; cistic fibrosis; resistance; pseudomonas
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Biofilms are the main growing form of microorganisms. These communities can be developed in both biological and nonliving surfaces, forming complex “cities”, protected from environmental agressions. Unfortunately, they also carry tolerance and resistance mechanisms to drugs which difficult their irradiation. The emergent threat of antimicrobial resistance (AMR) among bacterial, fungal or viral infections has driven the research community to explore effective alternatives to fight these critical pathogens. In this SI, we plan to explore in a deeper way, the potential bioactive effects of novel compounds to treat infections related to bacteria, fungi, viruses and parasites, with a particular interest in those directly related to AMR issues.
Dr. Célia Fortuna Rodrigues
Dr. Susana Patrícia Lopes
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biofilm
- resistance
- pathogens
- alternative treatment
- plant extract
- peptides
- nanotechnology
